Dr. Siegel on Biomarkers and Molecular Analysis

Video

David S. Siegel, MD, PhD, Chief, Multiple Myeloma at John Theurer Cancer Center, on biomarkers and molecular analysis.

David S. Siegel, MD, PhD, Chief, Multiple Myeloma at John Theurer Cancer Center, on biomarkers and molecular analysis.

Related Videos
Hua-Jay "Jeff" Cherng, MD
Joseph G. Jurcic, MD
Kathryn Beckermann, MD, PhD
Sunil Iyer, MD
Erin Crane, MD, MPH
Ibrahim Aldoss, MD
Minoo Battiwalla, MD
Arlene O. Siefker-Radtke, MD
Heinz-Josef Lenz, MD, FACP
Rohan Garje, MD, chief, Genitourinary Medical Oncology, Baptist Health Miami Cancer Institute
Related Content
Harout Semerjian, CEO of GlycoMimetics

Uproleselan Plus Chemotherapy Misses OS End Point in R/R AML

May 6th 2024
Article
OncLive On Air

Revisit the OncLive On Air Episodes From February 2024

March 18th 2024
Podcast
Rebecca Klisovic, MD, of University Hospitals Seidman Cancer Center

Which JAK Inhibitor in Myelofibrosis: Deciding Factors in Treatment Selection

May 3rd 2024
Article
Matthew Lunning, DO, FACP

Lunning and Jacobson Dissect the Role of CAR T-Cell Therapy in Follicular Lymphoma

November 30th 2023
Podcast
Angelos Stergiou, MD, ScD hc

SLS009 Plus Venetoclax/Azacitidine Produces Responses in R/R AML, Including ASXL1+ Disease

May 1st 2024
Article
FDA

NK Cell Therapy IGNK001 Receives FDA Orphan Drug Designation for AML

April 30th 2024
Article